Viswa Colluru, Enveda Biosciences
A Recursion veteran is mapping plant life to chart a course to new therapies — and investors like what they see
One of the earliest employees at AI biotech Recursion Pharmaceuticals is leading a new company, and he’s just closed a hefty Series A to get …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
